Correlation Between Clal Biotechnology and Enlivex Therapeutics

Can any of the company-specific risk be diversified away by investing in both Clal Biotechnology and Enlivex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Clal Biotechnology and Enlivex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Clal Biotechnology Industries and Enlivex Therapeutics, you can compare the effects of market volatilities on Clal Biotechnology and Enlivex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Clal Biotechnology with a short position of Enlivex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Clal Biotechnology and Enlivex Therapeutics.

Diversification Opportunities for Clal Biotechnology and Enlivex Therapeutics

0.23

Correlation Coefficient

Clal Biotechnology  Enlivex Therapeutics

Modest diversification

The 3 months correlation between Clal and Enlivex is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Clal Biotechnology Industries and Enlivex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enlivex Therapeutics and Clal Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Clal Biotechnology Industries are associated (or correlated) with Enlivex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enlivex Therapeutics has no effect on the direction of Clal Biotechnology i.e., Clal Biotechnology and Enlivex Therapeutics go up and down completely randomly.

Pair Corralation between Clal Biotechnology and Enlivex Therapeutics

Assuming the 90 days trading horizon Clal Biotechnology Industries is expected to generate 0.72 times more return on investment than Enlivex Therapeutics. However, Clal Biotechnology Industries is 1.38 times less risky than Enlivex Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Enlivex Therapeutics is currently generating about -0.07 per unit of risk. If you would invest  3,390  in Clal Biotechnology Industries on December 29, 2024 and sell it today you would lose (40.00) from holding Clal Biotechnology Industries or give up 1.18% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Clal Biotechnology Industries  vs.  Enlivex Therapeutics

Clal Biotechnology

Risk-Adjusted Performance

Very Weak

Over the last 90 days Clal Biotechnology Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong forward indicators, Clal Biotechnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Enlivex Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Enlivex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Clal Biotechnology and Enlivex Therapeutics

The main advantage of trading using opposite Clal Biotechnology and Enlivex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Clal Biotechnology position performs unexpectedly, Enlivex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enlivex Therapeutics will offset losses from the drop in Enlivex Therapeutics' long position.

The idea behind Clal Biotechnology Industries and Enlivex Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.